MAR 14, 2020 7:40 PM PDT

Mental Heath Implications of a Controversial Acne Drug

WRITTEN BY: Nouran Amin

Isotretinoin is a highly effective marketed treatment for acne that has long been believed to have an association with teen suicide and depression. Now, a study published in the Journal of the American Academy of Dermatology aims to debunk this association.

"Acne may not cause physical pain or impairment, but you do not want to leave acne untreated because that's a risk for mental health," said Misaki Natsuaki, an associate professor of psychology and director of the UCR Developmental Transitions Laboratory. "Undertreatment of acne itself is related to depression and anxiety, especially in females."

The study notes that many patients that are treated with isotretinoin—take the treatment because of severe acne, and that severity is known to be associated with mental health issues because of physical appearance implications

"We speculate that, although no one likes to have acne on his or her face, the prevalence of acne is high in adolescent years and it's somewhat expected to happen in teens," Natsuaki said. "However, for adults, acne may appear as a deviation from social norm."

Isotretinoin was marketed in 1982 as Absorica, Claravis, Amnesteem, Myorisan, and Zenatane. The drug was found to reduce acne after six months of use. However, in 1998, the Food and Drug Administration issued a warning of mental health implications of its use to depression, psychosis, suicidal ideation, and suicide. These actions have grew to cause controversy of its use.

"Given the psychiatric risk of acne itself, it is important for clinicians to optimize acne management which may include utilization of isotretinoin."

Source: Science Daily

About the Author
BS/MS
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
APR 20, 2022
Microbiology
Rapid AST: A key weapon in the fight against AMR
APR 20, 2022
Rapid AST: A key weapon in the fight against AMR
Despite the dire, well-documented risks of antimicrobial resistance (AMR), which threatens to kill 10 million people a y ...
MAY 13, 2022
Drug Discovery & Development
Multiple Mental Health Diagnoses are Increasingly Common. Why?
MAY 13, 2022
Multiple Mental Health Diagnoses are Increasingly Common. Why?
Mental illness has become increasingly common. The number of people with anxiety and depression, specifically, has stead ...
JUN 06, 2022
Drug Discovery & Development
New Antibiotic Shows Promise Against Treatment-Resistant Tuberculosis
JUN 06, 2022
New Antibiotic Shows Promise Against Treatment-Resistant Tuberculosis
A new class of antibiotics has shown promise in preclinical trials against drug-resistant tuberculosis. The correspondin ...
JUN 07, 2022
Cell & Molecular Biology
Advances in Laboratory Automation Research at the 2022 Labroots Virtual Event
JUN 07, 2022
Advances in Laboratory Automation Research at the 2022 Labroots Virtual Event
Labroots hosted its 6th Annual Laboratory Automation Virtual Event on May 18, 2022. The speaker roster for this free con ...
JUN 13, 2022
Microbiology
Mucus Contains Fungus-Fighting Molecules
JUN 13, 2022
Mucus Contains Fungus-Fighting Molecules
The human body plays host to a variety of microorganisms, including fungi like Candida albicans. Some strains of Candida ...
JUN 19, 2022
Drug Discovery & Development
Math Model Predicts Anti-inflammatory Drug Efficacy Post-heart Attack
JUN 19, 2022
Math Model Predicts Anti-inflammatory Drug Efficacy Post-heart Attack
Researchers created a mathematical model that can predict drug combinations that may one day help treat heart attacks. T ...
Loading Comments...